HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.

[EN] Objective: Previously, only the HLA-DRB1 alleles have been assessed in rheumatoid arthritis (RA). The aim of the present study was to identify the key major histocompatibility complex (MHC) susceptibility factors showing a significant association with anti-carbamylated protein antibody-positive...

Descripción completa

Detalles Bibliográficos
Autores: González, Antonio, Regueiro, Cristina, Casares-Marfil, Desire, Lundberg, Karin, Knevel, Rachel, Acosta-Herrera, Marialbert, Rodriguez-Rodriguez, Luis, Lopez-Mejias, Raquel, Pérez Pampín, Eva, Triguero-Martinez, Ana, Nuño, Laura, Ferraz-Amaro, Ivan, Rodriguez-Carrio, Javier, Lopez-Pedrera, Rosario, Robustillo-Villarino, Montse, Castañeda, Santos, Remuzgo-Martinez, Sara, Alperi, Mercedes, Alegre-Sancho, Juan J, Balsa, Alejandro, Gonzalez-Alvaro, Isidoro, Mera Varela, Antonio, Fernandez-Gutierrez, Benjamin, Gonzalez-Gay, Miguel A, Trouw, Leendert A, Grönwall, Caroline, Padyukov, Leonid, Martin, Javier, González Martínez-Pedrayo, Antonio
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/17701
Acceso en línea:https://pubmed.ncbi.nlm.nih.gov/33381897/
http://hdl.handle.net/20.500.11940/17701
Access Level:acceso abierto
Palabra clave:Anti-Citrullinated Protein Antibodies
Arthritis, Rheumatoid
Autoantibodies
Rheumatology
Arthritis
Population
Protein Carbamylation
HLA-DRB1 Chains
HLA-B8 Antigen
Alleles
autoanticuerpos
antígeno HLA-B8
Carbamilación de Proteína
alelos
reumatología
cadenas HLA-DRB1
artritis reumatoide
artritis
anti-carbamylated protein antibodies
shared epitope
IDIS
CHUS
id ES_97087dc62ca81ddbd8f7a7b707d3bbb3
oai_identifier_str oai:runa.sergas.gal:20.500.11940/17701
network_acronym_str ES
network_name_str España
repository_id_str
spelling HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.González, AntonioRegueiro, CristinaCasares-Marfil, DesireLundberg, KarinKnevel, RachelAcosta-Herrera, MarialbertRodriguez-Rodriguez, LuisLopez-Mejias, RaquelPérez Pampín, EvaTriguero-Martinez, AnaNuño, LauraFerraz-Amaro, IvanRodriguez-Carrio, JavierLopez-Pedrera, RosarioRobustillo-Villarino, MontseCastañeda, SantosRemuzgo-Martinez, SaraAlperi, MercedesAlegre-Sancho, Juan JBalsa, AlejandroGonzalez-Alvaro, IsidoroMera Varela, AntonioFernandez-Gutierrez, BenjaminGonzalez-Gay, Miguel ATrouw, Leendert AGrönwall, CarolinePadyukov, LeonidMartin, JavierGonzález Martínez-Pedrayo, AntonioAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidAutoantibodiesRheumatologyArthritisPopulationProtein CarbamylationHLA-DRB1 ChainsHLA-B8 AntigenAllelesautoanticuerposantígeno HLA-B8Carbamilación de Proteínaalelosreumatologíacadenas HLA-DRB1artritis reumatoideartritisanti-carbamylated protein antibodiesshared epitopeIDISCHUS[EN] Objective: Previously, only the HLA-DRB1 alleles have been assessed in rheumatoid arthritis (RA). The aim of the present study was to identify the key major histocompatibility complex (MHC) susceptibility factors showing a significant association with anti-carbamylated protein antibody-positive (anti-CarP+) RA. Methods: Analyses were restricted to RA patients who were anti-cyclic citrullinated peptide antibody negative (anti-CCP-), because the anti-CCP status dominated the results otherwise. Therefore, we studied samples from 1,821 anti-CCP- RA patients and 6,821 population controls from Spain, Sweden, and the Netherlands. The genotypes for ~8,000 MHC biallelic variants were assessed by dense genotyping and imputation. Their association with the anti-CarP status in RA patients was tested with logistic regression and combined with inverse-variance meta-analysis. Significance of the associations was assessed according to a study-specific threshold of P < 2.0 × 10-5 . Results: The HLA-B*08 allele and its correlated amino acid variant Asp-9 showed a significant association with anti-CarP+/anti-CCP- RA (P < 3.78 × 10-7 ; I2 = 0). This association was specific when assessed relative to 3 comparator groups: population controls, anti-CarP-/anti-CCP- RA patients, and anti-CCP- RA patients who were positive for other anti-citrullinated protein antibodies. Based on these findings, anti-CarP+/anti-CCP- RA patients could be separated from other antibody-defined subsets of RA patients in whom an association with the HLA-B*08 allele has been previously demonstrated. No other MHC variant remained associated with anti-CarP+/anti-CCP- RA after accounting for the presence of the HLA-B*08 allele. Specifically, the reported association of HLA-DRB1*03 was observed at a level comparable to that reported previously, but it was attributable to linkage disequilibrium. Conclusion: These results identify HLA-B*08 carrying Asp-9 as the MHC locus showing the strongest association with anti-CarP+/anti-CCP- RA. This knowledge may help clarify the role of the HLA in susceptibility to specific subsets of RA, by shaping the spectrum of RA autoantibodies.Ministerio de Educación, Cultura y DeporteInnovative Medicines InitiativeInstituto de Salud Carlos III (ISCIII)2021info:eu-repo/semantics/articlehttps://pubmed.ncbi.nlm.nih.gov/33381897/http://hdl.handle.net/20.500.11940/17701reponame:RUNA. Repositorio da Consellería de Sanidade e Sergasinstname:Servizo Galego de Saúde (SERGAS)Inglésinfo:eu-repo/semantics/openAccessoai:runa.sergas.gal:20.500.11940/177012026-06-12T08:40:47Z
dc.title.none.fl_str_mv HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
title HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
spellingShingle HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
González, Antonio
Anti-Citrullinated Protein Antibodies
Arthritis, Rheumatoid
Autoantibodies
Rheumatology
Arthritis
Population
Protein Carbamylation
HLA-DRB1 Chains
HLA-B8 Antigen
Alleles
autoanticuerpos
antígeno HLA-B8
Carbamilación de Proteína
alelos
reumatología
cadenas HLA-DRB1
artritis reumatoide
artritis
anti-carbamylated protein antibodies
shared epitope
IDIS
CHUS
title_short HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
title_full HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
title_fullStr HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
title_full_unstemmed HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
title_sort HLA- B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
dc.creator.none.fl_str_mv González, Antonio
Regueiro, Cristina
Casares-Marfil, Desire
Lundberg, Karin
Knevel, Rachel
Acosta-Herrera, Marialbert
Rodriguez-Rodriguez, Luis
Lopez-Mejias, Raquel
Pérez Pampín, Eva
Triguero-Martinez, Ana
Nuño, Laura
Ferraz-Amaro, Ivan
Rodriguez-Carrio, Javier
Lopez-Pedrera, Rosario
Robustillo-Villarino, Montse
Castañeda, Santos
Remuzgo-Martinez, Sara
Alperi, Mercedes
Alegre-Sancho, Juan J
Balsa, Alejandro
Gonzalez-Alvaro, Isidoro
Mera Varela, Antonio
Fernandez-Gutierrez, Benjamin
Gonzalez-Gay, Miguel A
Trouw, Leendert A
Grönwall, Caroline
Padyukov, Leonid
Martin, Javier
González Martínez-Pedrayo, Antonio
author González, Antonio
author_facet González, Antonio
Regueiro, Cristina
Casares-Marfil, Desire
Lundberg, Karin
Knevel, Rachel
Acosta-Herrera, Marialbert
Rodriguez-Rodriguez, Luis
Lopez-Mejias, Raquel
Pérez Pampín, Eva
Triguero-Martinez, Ana
Nuño, Laura
Ferraz-Amaro, Ivan
Rodriguez-Carrio, Javier
Lopez-Pedrera, Rosario
Robustillo-Villarino, Montse
Castañeda, Santos
Remuzgo-Martinez, Sara
Alperi, Mercedes
Alegre-Sancho, Juan J
Balsa, Alejandro
Gonzalez-Alvaro, Isidoro
Mera Varela, Antonio
Fernandez-Gutierrez, Benjamin
Gonzalez-Gay, Miguel A
Trouw, Leendert A
Grönwall, Caroline
Padyukov, Leonid
Martin, Javier
González Martínez-Pedrayo, Antonio
author_role author
author2 Regueiro, Cristina
Casares-Marfil, Desire
Lundberg, Karin
Knevel, Rachel
Acosta-Herrera, Marialbert
Rodriguez-Rodriguez, Luis
Lopez-Mejias, Raquel
Pérez Pampín, Eva
Triguero-Martinez, Ana
Nuño, Laura
Ferraz-Amaro, Ivan
Rodriguez-Carrio, Javier
Lopez-Pedrera, Rosario
Robustillo-Villarino, Montse
Castañeda, Santos
Remuzgo-Martinez, Sara
Alperi, Mercedes
Alegre-Sancho, Juan J
Balsa, Alejandro
Gonzalez-Alvaro, Isidoro
Mera Varela, Antonio
Fernandez-Gutierrez, Benjamin
Gonzalez-Gay, Miguel A
Trouw, Leendert A
Grönwall, Caroline
Padyukov, Leonid
Martin, Javier
González Martínez-Pedrayo, Antonio
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Anti-Citrullinated Protein Antibodies
Arthritis, Rheumatoid
Autoantibodies
Rheumatology
Arthritis
Population
Protein Carbamylation
HLA-DRB1 Chains
HLA-B8 Antigen
Alleles
autoanticuerpos
antígeno HLA-B8
Carbamilación de Proteína
alelos
reumatología
cadenas HLA-DRB1
artritis reumatoide
artritis
anti-carbamylated protein antibodies
shared epitope
IDIS
CHUS
topic Anti-Citrullinated Protein Antibodies
Arthritis, Rheumatoid
Autoantibodies
Rheumatology
Arthritis
Population
Protein Carbamylation
HLA-DRB1 Chains
HLA-B8 Antigen
Alleles
autoanticuerpos
antígeno HLA-B8
Carbamilación de Proteína
alelos
reumatología
cadenas HLA-DRB1
artritis reumatoide
artritis
anti-carbamylated protein antibodies
shared epitope
IDIS
CHUS
description [EN] Objective: Previously, only the HLA-DRB1 alleles have been assessed in rheumatoid arthritis (RA). The aim of the present study was to identify the key major histocompatibility complex (MHC) susceptibility factors showing a significant association with anti-carbamylated protein antibody-positive (anti-CarP+) RA. Methods: Analyses were restricted to RA patients who were anti-cyclic citrullinated peptide antibody negative (anti-CCP-), because the anti-CCP status dominated the results otherwise. Therefore, we studied samples from 1,821 anti-CCP- RA patients and 6,821 population controls from Spain, Sweden, and the Netherlands. The genotypes for ~8,000 MHC biallelic variants were assessed by dense genotyping and imputation. Their association with the anti-CarP status in RA patients was tested with logistic regression and combined with inverse-variance meta-analysis. Significance of the associations was assessed according to a study-specific threshold of P < 2.0 × 10-5 . Results: The HLA-B*08 allele and its correlated amino acid variant Asp-9 showed a significant association with anti-CarP+/anti-CCP- RA (P < 3.78 × 10-7 ; I2 = 0). This association was specific when assessed relative to 3 comparator groups: population controls, anti-CarP-/anti-CCP- RA patients, and anti-CCP- RA patients who were positive for other anti-citrullinated protein antibodies. Based on these findings, anti-CarP+/anti-CCP- RA patients could be separated from other antibody-defined subsets of RA patients in whom an association with the HLA-B*08 allele has been previously demonstrated. No other MHC variant remained associated with anti-CarP+/anti-CCP- RA after accounting for the presence of the HLA-B*08 allele. Specifically, the reported association of HLA-DRB1*03 was observed at a level comparable to that reported previously, but it was attributable to linkage disequilibrium. Conclusion: These results identify HLA-B*08 carrying Asp-9 as the MHC locus showing the strongest association with anti-CarP+/anti-CCP- RA. This knowledge may help clarify the role of the HLA in susceptibility to specific subsets of RA, by shaping the spectrum of RA autoantibodies.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://pubmed.ncbi.nlm.nih.gov/33381897/
http://hdl.handle.net/20.500.11940/17701
url https://pubmed.ncbi.nlm.nih.gov/33381897/
http://hdl.handle.net/20.500.11940/17701
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:RUNA. Repositorio da Consellería de Sanidade e Sergas
instname:Servizo Galego de Saúde (SERGAS)
instname_str Servizo Galego de Saúde (SERGAS)
reponame_str RUNA. Repositorio da Consellería de Sanidade e Sergas
collection RUNA. Repositorio da Consellería de Sanidade e Sergas
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414030793244672
score 15,301603